from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3763/lpqH

LFCtreatmentdescriptionclass of inhibitor

1.285

Amikacinug/mL Amikacintranslation

0.564

Cap5-10ug/mL Capreomycintranslation

0.220

Rox10-50 ug/mL Roxithromycintranslation

0.422

SM2-5 ug/mL Streptomycintranslation

0.750

Tet5-10 ug/mL Tetracyclinetranslation

-0.855

Rif0.2-5ug/mL Rifampicintranscription

-0.865

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.246

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.671

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.613

CPZ10-50 ug/mL Chlorpromazinerespiration

0.041

Clofazimine10-13 ug/mL Clofaziminerespiration

0.779

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.557

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.365

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.106

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.622

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.606

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.456

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.138

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.377

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.528

KCN5-20 ug/mL Potassium cyaniderespiration

-0.106

NaN30.2-2 mM Sodium aziderespiration

1.594

Nigericin50 uM Nigericinrespiration

-0.757

TRC10-150 ug/mL Triclosanrespiration

-0.249

TRZ10-25 ug/mL Thioridazinerespiration

-1.742

Valinomycin0.5-10 uM Valinomycinrespiration

0.961

ZnSO42 mM ZnSO4respiration

-0.673

menadione6-10 ug/mL Menadionerespiration

0.303

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.492

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.671

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.574

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.698

NRP_1Non-replicating persistence stage 1dosRassociated

0.451

Amp0.2mg/mL AmpicillincellWall

0.278

Cephalexin20-100 ug/mL CephalexincellWall

-0.005

Cerulenin0.32-5 ug/mL CerulenincellWall

0.859

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.359

EMB10-20 ug/mL EthambutolcellWall

0.672

Eta12-40 ug/mL EthionamidecellWall

0.793

INH0.2-0.4 ug/mL IsoniazidcellWall

0.011

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.368

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.939

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.226

BZA0.12 mg/mL BenzamidearomaticAmides

-0.194

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.069

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.663

H2O24 mM hydrogen peroxideDNAdamaging

-0.681

Levo10 ug/mL LevofloxacinDNAdamaging

0.069

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.940

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.220

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.023

UVUV-irradiationDNAdamaging

-0.263

ARP41-4 ug/mL Antitubercular compound ARP4?

0.847

Antimycin12.5-50 ug/mL Antimycin A?

0.530

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.141

PA_110-50 ug/mL Antitubercular compound PA-1?

0.472

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.475

PA8240.2-2 ug/mL PA-824?

-1.638

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.287

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.020

Verapamil50 uM Verapamil?

0.991

mercaptoethanol2 mM 2-Mercaptoethanol?

0.369

methoxatin10-20 ug/mL Methoxatin?